Neonatal Laryngeal Mask Airway Use In Resuscitation

A neonatal laryngeal mask airway (LMA), also called a supraglottic airway, provides an alternative route for positive-pressure ventilation when a newborn is not breathing effectively and face-mask ventilation is difficult or unsuccessful. It sits above the laryngeal opening rather than passing through the vocal cords, allowing trained clinicians to deliver oxygen and ventilation without immediate tracheal intubation.

This device has a valuable place in delivery-room care, particularly when mask seal, facial anatomy, secretions, or operator experience limits effective ventilation. It does not replace skilled airway assessment or endotracheal intubation, and it is unsuitable for every gestation, weight, or clinical emergency.

For clinicians in Australia, the topic fits within a broader perinatal safety system shaped by ANZCOR guidance, state-based hospital policies, neonatal retrieval services, and devices approved for local use. Practice may look different in a tertiary unit in Melbourne or Sydney than in a rural hospital preparing for transfer from northern Queensland or Western Australia.

The subject also belongs to the wider scientific setting represented by the FAOPS 2020 archive, which covered perinatal medicine, neonatal care, research, and international collaboration. Although the Tokyo congress was cancelled during the COVID-19 pandemic, its clinical themes remain relevant to contemporary newborn stabilisation.

When A Supraglottic Airway Is Considered

Initial newborn resuscitation still begins with warmth, assessment, positioning, airway opening, stimulation when appropriate, and respiratory support. If a baby remains apnoeic, gasping, or bradycardic, positive-pressure ventilation is the priority. A well-fitted face mask is commonly used first, but poor chest movement or a persistently low heart rate indicates that ventilation may not be effective.

An LMA can be considered when face-mask ventilation fails despite corrective steps, when a mask cannot be sealed, or when intubation is unsuccessful or delayed. It may also be useful when the clinician needs a more stable airway interface while preparing for neonatal retrieval or further airway management.

Guidance commonly supports use in newborns around 34 weeks’ gestation and above, although local protocols and the specific product’s instructions determine appropriate use. Evidence in extremely preterm or very low-birth-weight infants is more limited. A device that is too large may injure tissue or fail to seat, while one that is too small may leak and deliver inadequate tidal volume.

Benefits And Clinical Boundaries

The principal advantage is speed. A trained provider can insert a supraglottic airway without direct visualisation of the vocal cords, which can be helpful during a stressful delivery-room emergency. It may achieve more reliable ventilation than a face mask when facial features, secretions, or operator fatigue make the mask difficult to maintain.

An LMA also reduces the number of attempts at laryngoscopy in situations where intubation is challenging. This matters in units with variable exposure to neonatal airway procedures, including smaller facilities that stabilise a newborn before transfer to a neonatal intensive care service in Brisbane, Adelaide, Perth, or another major centre.

The limitations are equally important. An LMA does not protect the airway from aspiration as securely as a correctly placed endotracheal tube, and it is less suitable when there is major airway obstruction, significant facial or upper-airway abnormality, or a need for prolonged controlled ventilation. It may be ineffective in severe pulmonary hypoplasia or when very high ventilation pressures are required.

It should never be treated as a substitute for escalation. If the heart rate does not improve, the chest does not rise, or oxygenation remains poor, the team should reassess mask technique, device position, ventilation pressure, circulation, and the need for intubation or other advanced support.

Preparation Before Insertion

Preparation starts with equipment and people. The resuscitation team should check the warmer, oxygen and air supply, suction, self-inflating or flow-inflating ventilation device, appropriately sized masks, pulse oximeter, adhesive supports, and an alternative airway plan. In Australia, hospitals generally use products listed on the Therapeutic Goods Administration’s Australian Register of Therapeutic Goods, with procurement and approved indications governed by local policy.

The newborn should be positioned with the head in a neutral or slightly extended “sniffing” position, while excessive extension is avoided. Secretions should be cleared only when they obstruct breathing or ventilation; routine deep suction can cause trauma, bradycardia, and delay. The selected LMA should match the infant’s weight and the manufacturer’s instructions.

Team communication is a practical safety intervention. One clinician should manage the airway, another should provide ventilation and observe chest movement, and another should record timing, heart rate, oxygen saturation, and interventions. A clear verbal plan is particularly useful during a busy shift handover or when a retrieval team arrives from a regional service.

Insertion And Confirmation

The device is inserted along the hard palate and posterior pharynx until resistance is felt, following the technique taught for that specific model. Some neonatal supraglottic airways have an inflatable cuff, while newer designs may use a cuffless or anatomically shaped seal. Cuff inflation, if required, must follow the product instructions; excessive pressure can damage delicate pharyngeal tissue.

Effective placement is judged clinically rather than by insertion depth alone. The team should look for visible chest rise, improving heart rate, breath sounds, exhaled carbon dioxide when available, and improving oxygen saturation. A leak, absent chest movement, gastric inflation, or worsening bradycardia suggests displacement, obstruction, inadequate ventilation pressure, or another underlying problem.

Ventilation should use the lowest pressure that produces visible chest movement and clinical improvement. Routine high oxygen concentrations are avoided in newborn resuscitation; oxygen is adjusted according to gestation, preductal saturation targets, and current neonatal resuscitation guidance. The pulse oximeter should be placed on the right hand or wrist to measure preductal oxygenation.

If the airway fails to ventilate effectively, the provider should remove it and return to a face mask or proceed to endotracheal intubation according to the situation. Repeated blind attempts waste time and may cause trauma, so escalation thresholds should be agreed before insertion.

Training And Australian Service Delivery

Competence requires more than reading a device manual. Clinicians need supervised practice in newborn airway assessment, face-mask ventilation, supraglottic airway insertion, neonatal intubation, chest compressions, medication pathways, and post-resuscitation care. Simulation can reproduce difficult conditions such as poor lighting, maternal haemorrhage, shoulder dystocia, meconium-contaminated fluid, or an unexpected preterm birth.

Australian maternity services vary greatly in staffing and case volume. A tertiary centre in Sydney may have in-house neonatology, anaesthesia, and respiratory therapy support, whereas a remote Northern Territory or Far North Queensland facility may rely on a smaller team while contacting a neonatal retrieval service. Standardised checklists, telehealth support, equipment familiarity, and regular drills help reduce variation between these settings.

Training should also cover human factors. A team leader should allocate roles, call for senior help early, state the preferred backup airway, and use closed-loop communication. Debriefing after a resuscitation can identify equipment gaps, delays in calling retrieval, or uncertainty about who was authorised to perform a procedure.

Credentialing is determined by employers, professional standards, and local governance. A clinician who has inserted an LMA successfully in simulation may still need supervised clinical practice before independent use. Documentation should include the device type and size, number of attempts, ventilation response, complications, and the infant’s subsequent airway plan.

Prenatal Risk And Resuscitation Planning

Most newborns requiring an airway device are identified unexpectedly at birth, but prenatal information can influence preparation. Fetal growth restriction, congenital anomalies, hydrops, maternal diabetes, infection, and anticipated preterm delivery may increase the likelihood of respiratory or cardiovascular support. A multidisciplinary birth plan can ensure that the appropriate neonatal team, equipment, and transfer pathway are ready.

Genetic and structural information may also affect airway expectations. Families receiving counselling about diagnostic options can review resources on fetal karyotyping methods, including the distinctions between screening, cell-free DNA testing, and invasive diagnostic procedures. This information does not predict every airway event, but it may alert clinicians to syndromes or anomalies associated with difficult ventilation or intubation.

Maternal metabolic conditions also belong in perinatal planning. Dietary treatment for maternal phenylketonuria, for example, requires careful coordination before and during pregnancy, as described in maternal phenylketonuria management. Antenatal consultation can help the neonatal team anticipate growth, biochemical, or transition concerns without assuming that a supraglottic airway will be needed.

At birth, prenatal knowledge should support—not replace—real-time assessment. The baby’s breathing, tone, heart rate, colour, oxygen saturation, and response to ventilation determine the next action. A documented plan is useful, but it must remain flexible when clinical findings differ from expectations.

Care After Successful Ventilation

Improvement after LMA placement is a reason to continue assessment, not to end active management. The team should determine whether the infant is breathing independently, maintaining an acceptable heart rate, and meeting oxygenation targets. If respiratory effort remains weak, continuous positive airway pressure or further ventilation may be needed.

A newborn who required significant resuscitation should be observed for recurrent apnoea, respiratory distress, temperature instability, hypoglycaemia, acidosis, and neurological abnormalities. The LMA may be removed once spontaneous breathing is adequate and the infant can protect the airway, but removal should occur in a controlled setting with face-mask equipment and experienced staff immediately available.

If ongoing mechanical ventilation is required, an endotracheal tube is generally more secure and appropriate. The team should also consider transfer to a higher-level nursery or neonatal intensive care unit. Australian geography makes this decision time-sensitive: weather, road distance, flight availability, and the location of specialist teams can all affect stabilisation and transport.

Parents should receive a clear explanation of what happened, why the airway was used, how the baby responded, and what monitoring is planned. Accurate records support continuity between the birth hospital, retrieval service, and receiving unit, while respectful communication helps families understand an urgent intervention that may have occurred within minutes of birth.

Comparing Common Newborn Airway Options

Each airway method has a specific role. Face-mask ventilation is fast and widely available but depends heavily on a good seal. An LMA may provide a more consistent interface for a suitably sized newborn, while an endotracheal tube offers the most definitive airway control when ventilation must continue or aspiration risk is substantial.

Safe practice depends on matching the intervention to the newborn’s physiology, the provider’s skills, and the resources available. A supraglottic airway can shorten the path to effective ventilation, but its value is greatest when embedded in a complete resuscitation system with competent teams, reliable equipment, escalation plans, and appropriate postnatal monitoring.

Clinicians and maternity services should align local protocols with current ANZCOR recommendations, manufacturer instructions, and hospital governance. Regular simulation, stock checks, documented credentialing, and structured debriefing can make neonatal airway care more dependable across metropolitan, regional, and remote Australian settings.